Group
OpenWho we are
OpenGovernance
OpenWhat we do
OpenOur strategy
OpenInnovation
OpenResearch & Development
OpenGlobal markets & Technologies
OpenSustainable development
OpenStakeholders
OpenIndustry
OpenMarkets
OpenProcesses
OpenDiseases
OpenPublic health challenges
OpenElectronics
OpenEngineering & Construction
OpenScience & New energies
OpenLarge projects
Open
Home
healthcare
Preserve quality of life for patients, at home
in Europe
of expertise
Providing a complete suite of services
Once the diagnosis and the treatment are established by the physician, the long term treatment of these patients requires education, on-going support, intervention by trained nurses or technicians and implementation of therapy in the fields of respiratory, infusion, nutritional assistance and other therapeutic areas.
Our multi-disciplinary teams, which include pharmacists, nurses, nutritionists, healthcare professionals and technicians, work with the medical community, patients and their care givers to provide these services as cost-effectively as possible.
Respiratory
Through our respiratory Home Healthcare activity, and in compliance with international clinical guidelines, we help take care of patients suffering from chronic diseases.
Such as:
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive sleep apnea and other sleep disordered breathing
- Chronic respiratory failure
Infusion
By enabling and supporting drug administration at home, our infusion activity contributes to the management of:
- Diabetes
- Parkinson’s disease
- Pulmonary arterial hypertension
- Pain
Other pathologies concerned: Cancers, Nutritional deficiencies, Immunodeficiency, Rare diseases (such as Cystic fibrosis)…
Integrated solutions
To avoid complications in care and treatment, it is essential to identify high-risk patients, provide them with the tools, coaching and motivation they need to adhere to treatment, and monitor their vital signs in order to adapt our level of support and intervention by trained nurses or technicians.
Doing so helps prevent costly hospitalizations and diminished quality of life. We contribute actively to improving healthcare and economic outcomes by offering integrated solutions to practitioners, payers and patients. Our programs aim to contribute to improved disease management, patient support, and enhanced coordination and provision of care.
Medical devices
Air Liquide Healthcare offers products that are designed with patients’ needs in mind. Air Liquide Medical Systems is our dedicated subsidiary for the design of innovative medical devices to be used among others by patients suffering from chronic respiratory diseases.
Our offer includes:
- Ventilators and patient interfaces for patients requiring ventilation at home
- Patient interfaces such as masks and remote monitoring for patients suffering from sleep apneailitation programs
- Devices for aerosol therapy
Innovative and easy-to use medical devices improve the daily comfort of patients at home.
Our commitment
In complement to our areas of expertise, we maintain a stringent commitment to protecting vulnerable lives. Our number one concern is to meet patients’ safety and support needs.
Safety has always been at the heart of what we do. As a responsible company, we aim to provide safe and reliable service to our patients. We offer solutions for setting up efficient and secure treatment at home while respecting medical prescriptions at all times.
Air Liquide Healthcare ensures continuous training and qualification of its teams, evaluation and enhancement of equipment safety. We also develop processes and skills to identify potential hazards and safety precautions necessary at home.
Additionally, we support patients by working jointly with organizations committed to raising awareness and treating chronic diseases.
We had worked with IDF Europe (International Diabetes Federation Europe), the European chapter of the International Diabetes Federation in its information and awareness-raising activities targeting patients with this condition, the general public, and public policymakers in Europe.
We also have supported IDF Europe to advance diabetes research with 2018 Young Researcher Award. The purpose is to reward the work of a young researcher under 40 who is involved in research projects aimed at improving the health of patients with diabetes.
All around the world, we support patient associations in countries we are present in.
